Project name: Northern Ireland General Practice Heart Failure QOF Register Review Collaborative Working.
Project Summary:
The Collaborative working will improve the accuracy of read coding for existing Heart Failure patients and aim to find those with a missing diagnosis through reviewing patients who have Heart Failure associated risk factors. The benefits include data cleansing and validation of the Heart Failure QOF registers, increasing QOF outcome generation and ultimately, this benefit patients through better diagnosis, review and improved management.
As part of the Project, ICS are performing register reviews in 12 GP practices across Northern Ireland, with Salisbury Medical Practice being one of these. The practice will provide Interface Clinical Services (“ICS”) with access to all patient records within the GP Practice to facilitate the Heart Failure QOF register review. Using the report provided by ICS, the practice will review all appropriate patient records and create a Heart Failure management plan for each patient to improve their Heart Failure care. Services provided by ICS will be funded by Novartis.
Planned Milestones:
Milestones with Salisbury Medical Practice
Milestone | Milestone Date |
|---|---|
Generation of ICS report | 1 month post project initiation |
Completion of Consultation day by practice Heart Failure MDT | 1 month after completion of register review by ICS |
Overall Project Milestones
Milestone | Milestone Date |
|---|---|
Group 1 (Practices 1, 2 & 3) complete database review | 3 months after Project initiation, |
Group 1 (Practices 1, 2 & 3) complete Consultation Day | 4 months after Project initiation, |
Group 2 (Practices 4, 5 & 6) complete database review | 6 months after Project initiation, |
Group 2 (Practices 4, 5 & 6) complete Consultation Day | 7 months after Project initiation, |
Group 3 (7, 8 & 9) complete database review | 9 months after Project initiation, |
Group 3 (7, 8 & 9) complete Consultation Day | 10 months after Project initiation, |
Group 4 (10, 11 & 12) complete database review | 12 months after Project initiation, |
Group 4 (10, 11 & 12) complete Consultation Day | 13 months after Project initiation, |
Expected Benefits:
The benefits to the patient include:
- Proactive assessment and earlier detection of Heart Failure
- Greater opportunity for initiation and optimisation of evidence-based Heart Failure therapies
- Improvement in quality of care
- Improved experience of the Heart Failure service
The benefits to the relevant NHS GP practice include:
- data cleansing and validation of QOF
- increasing QOF outcome generation
The benefits to Novartis include:
- Creation of more opportunities for the appropriate use of cardiology licensed medicines in line with NICE and clinical guidelines, including Novartis’ medicine
- Better understanding of customers’ and patients’ needs specific to the management of Heart Failure but indeed more widely
- Greater insight into the practical challenges and workings of delivering a high quality and sustainable Heart Failure Service
- Improved reputation
Start Date & Duration:
Salisbury Medical Practice
Start date: April 2022
Duration: 2 months from commencement of services being provided by ICS
Overall Collaborative Working Project
Start date: April 2022
Duration: up to 13 months
UK2204131351
Project Name: Northern Ireland General Practice Heart Failure QOF Register Review Collaborative Working
Completion Date: November 2022
Outcome Summary:
For an individual practice the Collaborative working has improved the accuracy of read coding for existing Heart Failure patients and found those with a missing diagnosis through reviewing patients who have Heart Failure associated risk factors
Key Project Outcomes Data:
The relevant NHSGP practice provided Interface Clinical Services (“ICS”) with access to all patient records within the GP Practice facilitating the Heart Failure QOF register review. Using the report provided by ICS, the GP Practice has reviewed all appropriate patient records and created a Heart Failure management plan for each patient to improve their Heart Failure care. The heart failure management plan has followed local guidelines The services are detailed below in Outcomes:
Outcomes:
Service | Outcome | Further actions |
|---|---|---|
Interrogation of Heart Failure QOF registers at the relevant GP practice by 3rd party provider, ICS, to update the registers and find Heart Failure patients who are currently (un)diagnosed and/or not on the existing Heart Failure QOF registers. | 48 added to HF register by GPP, all clinical notes reviewed first by gpp | GPP reviewed and made apporproaute entry to establish correct registrreation of HF for these pts, |
Consultation day provided by ICS to staff members at the GP practice to review results | No |
|
Percentage increase inpatients on the Heart Failure register | 68.2% |
|
Number of newly identified Heart Failure patients | 12 |
|
Increase in number of patients receiving NICE recommended therapy from baseline | 20 | All reviewed and actioned by GPP/GP in joint review process with HF nurse |
Number of patients referred into 2nd care service | 1 | Prevented 10 referrals |
Conclusion:
Please see outcomes and further actions in above table
BeSure UK2403227498
March 2024